Clinical Laboratory Management Association: Mary Beth Hepp has been appointed CEO of the
Clinical Laboratory Management Association (CLMA), which recently relocated from Wayne, Pa. to Chicago. Hepp previously served as executive director for the Society for Gastroenterology Nurses and Associates and also worked for the American Red Cross in a number of capacities. [February 2010]
FDA: Jeffrey E. Shuren, M.D., J.D., has been appointed director of the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration (FDA). He has served as acting director of CDRH since the August 2009 departure of Daniel Schultz, M.D. Since joining the FDA in 1998, Shuren has held policy and planning positions including acting deputy commissioner for policy, planning, and budget; associate commissioner for policy and planning; and medical officer in the Office of Policy. [January 2010]
RBC Capital Markets: Bill Bonello has joined the Minneapolis office of RBC Capital Markets, the corporate and investment banking arm of Royal Bank of Canada, where he has been appointed managing director and senior research analyst for healthcare. Bonello was previously senior vice president of investor relations at LabCorp. [January 2010]
AACC: Catherine Hammett-Stabler, Ph.D., has assumed the presidency of the American Association for Clinical Chemistry (AACC; Washington, D.C.). She is a professor in the Department of Pathology and Laboratory Medicine at the University of North Carolina and the director of the McLendon Clinical Laboratories Core Laboratory. Hammett-Stabler replaces AACC Past President Barbara M. Goldsmith, Ph.D., and come 2011, will be succeeded by President-Elect Ann M. Gronowski, Ph.D. [January 2010]
Recombinant Data: Matvey B. Palchuk, M.D., M.S., has joined clinical data services company Recombinant Data Corp. (Newton, Mass.) as director of medical informatics. Palchuk, an instructor at Harvard Medical School, was previously an interlingua architect at Harvard's Center for Biomedical Informatics. He has also worked as a senior medical informatics specialist in the clinical informatics research and development group at the Partners HealthCare System. [December 2009]
ViraCor-IBT Laboratories (Kansas City, Missouri) has named Mark Roberts, Ph.D. as the companys president and chief executive officer. Prior to joining ViraCor-IBT, Roberts served as general manager for Thermo Fisher Scientifics Seradyn business unit. Roberts will replace the most recent company president, John Martin, who will assume the responsibilities of chief operating officer.
NeoGenomics: Jack G. Spitz has been appointed vice president of laboratory operations at NeoGenomics (Ft. Myers, Fla.). Spitz was previously senior executive director of operations for Dermpath Diagnostics, a division of Quest Diagnostics that was formerly part of Ameripath. Prior to joining Ameripath in 2006, Spitz served as director of operations for Genova Diagnostics. [December 2009]
On-Q-ity: Gary Palmer, M.D., JD, MPH, has been appointed chief medical officer of On-Q-ity (Waltham, Mass.), the cancer diagnostics company formed earlier this year via the merger of The DNA Repair Company and CELLective Diagnostics. On-Q-ity has raised $26 million in Series A funding. Palmer, a medical oncologist, was previously vice president of medical affairs at Genomic Health. [December 2009]
Affymetrix: Andrew J. Last, Ph.D., has been promoted to chief commercial officer of Affymetrix (Santa Clara, Calif.). His responsibilities will include sales, marketing, and service for the GeneChip maker, which transferred ownership of its CLIA-certified laboratory to Navigenics in March. Prior to joining Affymetrix, Last served on the leadership team of BD Biosciences Cell Analysis Unit, where he was vice president for global marketing and strategic planning and general manager of the San Diego-based Pharmingen business. [December 2009]
Health Discovery Corporation: Thomas Gallagher has been appointed executive vice president and managing director of global IP strategies at Health Discovery Corporation (Savannah, Ga.). He will be responsible for building new licensing and development relationships for the molecular diagnostics company. Gallagher spent 14 years on Wall Street as a securities and business transaction lawyer and was most recently a vice president at Goldman, Sachs & Co. [December 2009]
Insight Imaging: Clark Nielsen has been appointed senior vice president of sales for Insight Imaging (Lake Forest, Ill.), a provider of retail and wholesale diagnostic imaging services. He has 20 years of experience in sales roles at Philips Healthcare, where he most recently served as imaging systems region sales vice president. [November 2009]